Cargando…
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer
Bladder cancer remains one of the most expensive cancers to treat in the United States due to the length of required treatment and degree of recurrence. In order to treat bladder cancer more effectively, targeted therapies are being investigated. In order to use targeted therapy in a patient, it is...
Autores principales: | Smolensky, Dmitriy, Rathore, Kusum, Cekanova, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063594/ https://www.ncbi.nlm.nih.gov/pubmed/27784990 http://dx.doi.org/10.2147/DDDT.S112113 |
Ejemplares similares
-
Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro
por: Smolensky, Dmitriy, et al.
Publicado: (2015) -
Animal models and therapeutic molecular targets of cancer: utility and limitations
por: Cekanova, Maria, et al.
Publicado: (2014) -
Animal model of naturally occurring bladder cancer: Characterization of four new canine transitional cell carcinoma cell lines
por: Rathore, Kusum, et al.
Publicado: (2014) -
Detection of carcinogen-induced bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019) -
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
por: Rathore, Kusum, et al.
Publicado: (2015)